Susquehanna International Group
ORIA

Susquehanna International Group’s Orion Biotech Opportunities Corp. Class A Ordinary Share ORIA Stock Holding History

Susquehanna International Group’s Portfolio ORIA Stock Details ORIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-10,006
Closed -$102K – 13713
2023
Q1 		$102K Sell
10,006
-11,357
-53% -$115K ﹤0.01% 11276
2022
Q4 		$215K Buy
+21,363
New +$213K ﹤0.01% 9957

Susquehanna International Group's ORIA Position: Q2 2023 in Review

Susquehanna International Group sold out of Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) in Q2 2023, closing a stake of 10,006 shares — an estimated $102K sold.

Susquehanna International Group first reported a position in ORIA in Q4 2022 and held it in 2 quarters. The position peaked at $215K in Q4 2022. 0 funds tracked by Wall St. Rank hold ORIA as of Q2 2023.

  • Susquehanna International Group reported no remaining Orion Biotech Opportunities Corp. Class A Ordinary Share position as of Q2 2023 after selling out during the quarter.
  • Susquehanna International Group sold 10,006 Orion Biotech Opportunities Corp. Class A Ordinary Share shares in Q2 2023, an estimated $102K.
  • Susquehanna International Group first reported a position in Orion Biotech Opportunities Corp. Class A Ordinary Share in Q4 2022 and held it in 2 quarters.
  • Susquehanna International Group's Orion Biotech Opportunities Corp. Class A Ordinary Share position peaked at $215K in Q4 2022.
  • 0 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Class A Ordinary Share as of Q2 2023.

Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.